Royalty Pharma
| Company type | Public |
|---|---|
| Nasdaq: RPRX | |
| Industry | Biopharmaceuticals |
| Founded | 1996 |
| Founder | Pablo Legorreta |
| Headquarters | New York City, United States |
| Website | www |
Royalty Pharma is a private equity investor firm founded in 1996. It purchases the rights to royalties on future drug sales. It claims to own partial rights to 7 of the top 30 selling drugs in the United States.
As of 2017, it is valued at $15 billion.